Drawing for BASALIN

USPTO serial 79136321

BASALIN

Reviewed by CopyMark Law Group

Reg. 4615574Status 706Registered
Filing date
Status date
Registration date
Oct 7, 2014
Examiner
JACKSON, STEVEN W
Law office
Historical data usage

What this means

This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.

Need help with BASALIN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Andrew T. Rissler

Andrew T. Rissler Patel & Almeida, P.C.20700 Ventura Blvd., Suite 235Woodland Hills, CA 91364United States

Goods and services

ClassDescriptionStatusFirst use
005Medicines for human purposes, namely, insulin; raw material medicine, namely, insulin; Biomedicine for treating diabetes; pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Biological preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, diabetes, and anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines cognitive disorders; chemical preparations for medical purposes, namely, for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Chemical preparations for pharmaceutical purposes, namely, for the treatment of endocrine related diseases and disorders; Pharmaceutical preparations, namely, insulin for injection; [ dietetic substances, namely, dietetic sugar, pasta and crackers adapted for medical use; ] drugs, namely, anti-diabetic pharmaceuticals for medical purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 3, 2026NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jun 25, 2026INNAINVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE—
Dec 7, 2025INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Jun 19, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
Apr 7, 2025NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Apr 7, 202571AGREGISTERED-SEC.71 ACCEPTED—
Apr 7, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jan 24, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
Nov 7, 2024ES71TEAS SECTION 71 RECEIVED—
Oct 7, 2023REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED—
May 12, 2023RNWLINTERNATIONAL REGISTRATION RENEWED—
Nov 3, 2021INNPPARTIAL INVALIDATION PROCESSED BY THE IB—
Sep 27, 2021INPSPARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Sep 27, 2021INPCINVALIDATION PROCESSED—
Sep 11, 2021INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Jan 11, 2021NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Jan 11, 202171AGREGISTERED-SEC.71 ACCEPTED—
Jan 10, 2021APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Oct 2, 2020ES71TEAS SECTION 71 RECEIVED—
Oct 7, 2019REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Apr 7, 2017ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Jun 2, 2015CORRCORRECTION FROM IB ENTERED - NO REVIEW REQUIRED—
Jun 1, 2015CRCVCORRECTION TRANSACTION RECEIVED FROM IB—
Apr 3, 2015FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Mar 11, 2015FICSFINAL DISPOSITION NOTICE SENT TO IB—
Mar 11, 2015FIMPFINAL DISPOSITION PROCESSED—
Jan 7, 2015FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Oct 7, 2014R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 22, 2014GPNXNOTIFICATION PROCESSED BY IB—
Jul 22, 2014NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 22, 2014PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 2, 2014OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jul 2, 2014OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jul 2, 2014NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 19, 2014PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jun 19, 2014CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 18, 2014RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Jun 11, 2014ALIEASSIGNED TO LIE—
Dec 11, 2013GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Dec 11, 2013GNSLLETTER OF SUSPENSION E-MAILED—
Dec 11, 2013CNSLSUSPENSION LETTER WRITTEN—
Dec 10, 2013TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 10, 2013RFNTREFUSAL PROCESSED BY IB—
Dec 9, 2013CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 9, 2013TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 18, 2013RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Nov 18, 2013RFRRREFUSAL PROCESSED BY MPU—
Nov 15, 2013RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Nov 14, 2013CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 8, 2013DOCKASSIGNED TO EXAMINER—
Oct 15, 2013MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 9, 2013NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 3, 2013REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance